Clinical
Pharmacology
a matter of enthusiasm!
Membership
Become a member of AGAH!
You can contribute your competence to the professional scientific organisation of medicinal product research.Events
Current Events of the AGAH
Read actual news about current activities of the AGAH. Participation pays off!
About us
What is the AGAH?
The Association for Applied Human Pharmacology (AGAH) focuses on exploratory medicinal product development and human pharmacological research
AGAH - Get to know us!
The Association for Applied Human Pharmacology (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. - AGAH) as a specialist medical-academic organisation focuses on exploratory medicinal product development and human pharmacological research.
AGAH sees itself as an organisation for everyone dealing with clinical pharmacological test programs, studies in the target population in early-stage medicinal product development and translational topics.
Details
Working groups of AGAH
Focus of our work
Our work focuses on the conception and planning of clinical pharmacological trials, their approval and testing processes, as well as their practical implementation and evaluation. Apart from the traditional areas of pharmacokinetics and pharmacodynamics, it covers the inclusion of biomarkers in clinical trials and the consideration of statistical and pharmacometric methods in the planning and evaluation of trials.
Researchers and developers from universities, (bio)pharmaceutical industry, contract research organisations, authorities and ethics committees come together in the AGAH. The interfaces to the preclinical stage and the later phases of clinical trials are not excluded but consciously and actively integrated into our academic work.
Responsible for the people
We are conscious of our special responsibility, which comes with the implementation of research projects in humans, especially when the trial participants do not gain any personal benefit of participating in the trials – a particular type of ethical challenge, especially in the early phases of clinical trials.
High-quality research projects with particular attention paid to safety aspects are therefore most important for the people participating as test subjects in these trials, but also for the knowledge gained for subsequent application in treatment. As an academic organisation we strive to make a contribution here.
International context
We started our work as a national organisation over 25 years ago and have moved with the times – today research is international, cross-border and varied; for example, the AGAH is a founding member of EUFEMED (European Federation of Exploratory Medicines Development), a consortium of specialist organisations with the same orientation for discussing and promoting early-stage medicinal product development at a European level.
Progress through exchange, dialogue and cooperation - this is how AGAH sees itself today and in the future.
Partner organisations
Current events
-
6. October 2022 - 7. October 2022
AGAH – Applied Course in Pharmacokinetics (2 days) – Face2Face Workshop
Oberursel, -
17. November 2022 - 23. November 2022
Introductory Course in Exploratory Medicines Development – Part I
digitale Veranstaltung/digital event, -
26. January 2023 - 2. February 2023
Introductory Course in Exploratory Medicines Development – Part II
digitale Veranstaltung für Mitglieder/digital event for Members, -
24. May 2023 - 26. May 2023
4rd EUFEMED Conference, Berlin (Germany)
Kaiserin-Friedrich-Haus, Berlin (Germany),
Note of condolence
Die AGAH trauert um Christian Hinze, der im Alter von 72 Jahren im November 2021 nach schwerer Krankheit verstorben ist.
Christian Hinze war Gründungsmitglied der AGAH und hat dem erweiterten Vorstand der AGAH von 1991 bis 2021 angehört. Er hat die Vereinsarbeit in vielfältigen Funktionen unterstützt, sei es als Kassenwart, Leiter von Arbeitsgruppen, Mitglied in Programmkomitees, Vortragender zu Themen der Humanpharmakologie oder als Dozent im Introductory Course in Exploratory Medicines Development.
Christian Hinze war ein „Urgestein“ der AGAH und sein Beitrag zum Erfolg der Gesellschaft war maßgeblich. Er hat zu kritischen Diskussionen angeregt, seine besondere und belebende Sicht auf die Dinge hat uns vorangebracht. Wir werden ihn und seinen trockenen Humor vermissen.
Unsere Anteilnahme gilt seiner Frau und seiner Familie. Unsere Wertschätzung für Christian mag ihnen ein kleiner Trost sein in schweren Zeiten.
Der Vorstand der AGAH